Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine
- 3 January 1989
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (2) , A46-A53
- https://doi.org/10.1016/0002-9149(89)90393-7
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure.Circulation, 1985
- Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.Circulation, 1985
- Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.Circulation, 1985
- Acute dose range study of milrinone in congestive heart failureThe American Journal of Cardiology, 1985
- Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.Journal of Clinical Investigation, 1985
- Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.Circulation, 1984
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying diseaseJournal of the American College of Cardiology, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978